金吾财讯 | 国药控股(01099)公告,截至2024年9月30日止九个月,附属公司中国医疗器械有限公司录得营业总收入560.46亿元人民币,同比减少6.94%;归母净利4.09亿元人民币,同比减少39%。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.